These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4207187)

  • 1. Two new inhibitory activities in blood of mice with delayed hypersensitivity, after challenge with specific antigen.
    Salvin SB; Nishio J; Shonnard JT
    Infect Immun; 1974 Apr; 9(4):631-5. PubMed ID: 4207187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
    Youngner JS; Salvin SB
    J Immunol; 1973 Dec; 111(6):1914-22. PubMed ID: 4356326
    [No Abstract]   [Full Text] [Related]  

  • 3. Type I and II interferons and migration inhibitory factor: production in Mycobacterium bovis BCG-infected mice desensitized with old tuberculin or lipopolysaccharide.
    Youngner JS; Salvin SB
    Infect Immun; 1978 Mar; 19(3):912-4. PubMed ID: 346489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
    Kato K; Yamamoto K
    Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo studies on the cellular source of migration inhibitory factor in mice with delayed hypersensitivity.
    Salvin SB; Sonnenfeld G; Nishio J
    Infect Immun; 1977 Sep; 17(3):639-43. PubMed ID: 332631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components.
    Salvin SB; Ribi E; Granger DL; Youngner JS
    J Immunol; 1975 Jan; 114(1 Pt 2):354-9. PubMed ID: 1090652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The phenotypic expression of the genes controlling the yield of a factor suppressing macrophage migration to Candida albicans antigens and tuberculin in mice].
    Vorob'ev KV; Gankovskaia LV; Koval'chuk LV; Vasil'ev OD
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):109-12. PubMed ID: 2150140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of human amniotic fluid.
    Bergman N; Bercovici B; Sacks T
    Am J Obstet Gynecol; 1972 Oct; 114(4):520-3. PubMed ID: 4631759
    [No Abstract]   [Full Text] [Related]  

  • 9. [Delayed hypersensitivity and nonspecific cellular immunity. The conditions determining the maximally expressed immunity activity].
    Gordienko SM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 May; (5):77-82. PubMed ID: 2941945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of bacterial hypersensitivity.
    Bacigaluppi JE; Negroni R; Severino H
    Ann Allergy; 1974 Jul; 33(1):16-22. PubMed ID: 4599469
    [No Abstract]   [Full Text] [Related]  

  • 11. Migration of natural suppressor cells from bone marrow to peritoneal cavity by live BCG.
    Kato K; Yamamoto K; Kimura T
    J Immunol; 1985 Dec; 135(6):3661-8. PubMed ID: 2933452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological safety of essential oils used in complementary therapies and the activity of these compounds against bacterial and fungal pathogens.
    Maudsley F; Kerr KG
    Support Care Cancer; 1999 Mar; 7(2):100-2. PubMed ID: 10089091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Delayed hypersensitivity and nonspecific cellular immunity. The cytotoxic activity of macrophages, natural and antibody-dependent killer cells].
    Gordienko SM
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):57-61. PubMed ID: 3087122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between inhibition of indicator cell migration and tuberculin hypersensitivity in patients with suspected tuberculous inflammation of the uveal tissue.
    Kalafut F; Cernák A
    Folia Biol (Praha); 1977 Jan; 23(1):40-7. PubMed ID: 66161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K; Yamamoto K; Kimura T; Azuma I; Askenase PW
    J Immunol; 1984 Jun; 132(6):2790-5. PubMed ID: 6202761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between delayed hypersensitivity and immunity in tuberculosis.
    Youmans GP
    Am Rev Respir Dis; 1975 Feb; 111(2):109-18. PubMed ID: 803355
    [No Abstract]   [Full Text] [Related]  

  • 17. Murine spleen leukocytes as an inhibitable target cell system for human MIF.
    Górski AJ
    Cell Immunol; 1974 May; 12(2):315-22. PubMed ID: 4617631
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes.
    Chess L; Rocklin RE; MacDermott RP; David JR; Schlossman SF
    J Immunol; 1975 Jul; 115(1):315-7. PubMed ID: 50357
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of bacterial colonization of the newborn in a maternity hospital. I.
    McAllister TA; Givan J; Black A; Turner MJ; Kerr MM; Hutchison JH
    Scott Med J; 1974 May; 19(3):119-24. PubMed ID: 4208384
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular source of interferons in the circulation of mice with delayed hypersensitivity.
    Sonnenfeld G; Salvin SB; Youngner JS
    Infect Immun; 1977 Nov; 18(2):283-90. PubMed ID: 336540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.